Eli Lilly to acquire privately held SiteOne
May 27 (Reuters) - Eli Lilly LLY.N will acquire privately held SiteOne Therapeutics, the companies said on Tuesday, giving the drugmaker access to an experimental non-opioid pain drug.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
Anthropic Revenue Surpasses OpenAI for First Time, IPO as Early as October

Meta Is About to Launch a Consumer-Facing AI Model, and OpenAI Is About to Have Its IPO, Making Now a Good Time to Buy Meta Stock

IonQ vs. Rigetti Computing: Which Quantum Computing Stock Has the Edge Now?

Memory Chips Drive Samsung Earnings Surge, But Stock Price Opens High and Closes Lower: Why?

Is Bitcoin Reaching a Local Top? Institutional Demand vs. Retail Sentiment at $70,000

Tradingkey







